Newsletter | January 10, 2024

01.10.24 -- Are Radiopharmaceuticals The Next ADCs?


Webinar: Slow The Burn Part 2: A Deeper Dive On How To Mitigate Financial Risk Before Selecting An Outsourcing Vendor

Join us January 23 as we dive deeper into the common red flags to look for, the critical questions to ask, and best practices for safeguarding your trial’s budget. Click here to learn more.


Ahead Of The Curve On Radiopharmaceuticals

Former president of Cardinal Health’s nuclear and precision health solutions group Tiffany Olson discusses her work on Bayer's Xofigo and how she anticipated the rise of radiopharmaceuticals.

Life Sciences M&A Outlook: Challenges And Opportunities In 2024

A robust and competitive M&A environment in 2024 will require dealmakers to exercise greater discernment and discipline in target selection and pricing strategies.

CEO Q&A: David Younger, Ph.D.

Life Science Leader catches up with David Younger, cofounder and CEO of A-Alpha Bio, about the promise of molecular glues, the challenges of standing up a new company, and collaborating with Big Pharma.


4 Keys To Allo In 2024 With Poseida Therapeutics' Kristin Yarema, Ph.D.

Kristin Yarema, Ph.D., CEO, Poseida Therapeutics, sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies. Listen now!


From Nanoformed Powder To 3D Printable Ink

3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials.

Conference Focuses On Need For Diversity In Clinical Research, Trials

Learn about the inaugural Women in Research Conference hosted by Black Women in Clinical Research and how this organization is driving change and pursuing more diverse clinical trials and research.


Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: